StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

Earnings

CTT Pharmaceutical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of CTT Pharmaceutical's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

CTT Pharmaceutical has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When CTT Pharmaceutical puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases CTT Pharmaceutical filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?